Risk Factors of Radiation Pneumonitis
NCT00155909 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 53
Last updated 2005-11-23
Summary
A prospective observational study to evaluate clinical, dosimetrical, functional, and biological factors in predicting radiation pneumonitis.
Conditions
- Radiation Pneumonitis
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Chun-Ru Chien, M.D. · National Taiwan University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-31
- Completion
- 2006-06-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation
NCT01580579 ·Status: COMPLETED
-
Smoking Cessation in Head and Neck Cancer Patients Receiving Curative Radiation Therapy
NCT02251730 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury
NCT00631839 ·Status: UNKNOWN
-
The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
NCT00751543 ·Status: UNKNOWN ·Phase: NA
-
Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial
NCT03077854 ·Status: UNKNOWN ·Phase: NA
-
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation
NCT02189967 ·Status: COMPLETED ·Phase: NA
-
Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy Resistance
NCT05906329 ·Status: UNKNOWN ·Phase: NA
-
Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation
NCT01745484 ·Status: COMPLETED ·Phase: NA
-
Moderate Hypofractionated Radiotherapy for Lung Cancer
NCT03833193 ·Status: UNKNOWN ·Phase: NA
-
Dose-painting Radiation for LA-NSCLC
NCT05031533 ·Status: RECRUITING ·Phase: NA
-
Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect
NCT03825510 ·Status: COMPLETED ·Phase: PHASE2
-
Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer
NCT02448992 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Functional Imaging in Lung SBRT
NCT03121300 ·Status: COMPLETED
-
Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy
NCT06159660 ·Status: RECRUITING
-
Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot Study
NCT00585819 ·Status: WITHDRAWN ·Phase: NA
-
Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma
NCT07111104 ·Status: COMPLETED
-
Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity
NCT00178230 ·Status: COMPLETED
-
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
NCT02688036 ·Status: UNKNOWN ·Phase: PHASE3
-
Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer
NCT00246116 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
NCT00551369 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Lung Function After Radiation Therapy
NCT01039649 ·Status: COMPLETED
-
Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan
NCT01913769 ·Status: UNKNOWN
-
Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer
NCT05150145 ·Status: RECRUITING ·Phase: NA
-
Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence
NCT00915005 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Volumetric Radiotherapy in Prostate Cancer
NCT02423889 ·Status: COMPLETED ·Phase: PHASE2